Clarivate amends 8 — K with pro forma financials for $600 million LS&H sale to Altaris affiliate
Clarivate issued an amended Form 8-K/A detailing the completed sale of its Life Sciences and Healthcare business to an Altaris affiliate for USD 600 million. The transaction closed on Oct. 6, 2026, with Clarivate receiving USD 488.4 million in cash at close, net of closing costs and working-capital adjustments. The dea